We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.1B
AUM Growth
-$3.82B
(-19%)
Cap. Flow
-$3.99B
Cap. Flow
% of AUM
-24.75%
Top 10 Holdings %
Top 10 Hldgs %
22.06%
Holding
1,193
New
41
Increased
285
Reduced
579
Closed
205
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$107M |
| 2 |
Merck
MRK
|
+$99.8M |
| 3 |
Procter & Gamble
PG
|
+$91.5M |
| 4 |
Pembina Pipeline
PBA
|
+$76.5M |
| 5 |
Cisco
CSCO
|
+$65.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Medtronic
MDT
|
+$121M |
| 3 |
Microsoft
MSFT
|
+$112M |
| 4 |
NextEra Energy
NEE
|
+$73.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$69.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.3% |
| 2 | Healthcare | 16.03% |
| 3 | Financials | 14.08% |
| 4 | Consumer Staples | 10.18% |
| 5 | Communication Services | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Vanda Pharmaceuticals
VNDA
$302M
| $117K | ﹤0.01% |
8,600
-8,600
| -50% | -$120K |
|
|
PDLI
902
DELISTED
PDL BioPharma, Inc.
PDLI
| $114K | ﹤0.01% |
51,900
-51,900
| -50% | -$139K |
|
903
Vishay Intertechnology
VSH
$5.43B
| $113K | ﹤0.01% |
6,689
-42,684
| -86% | -$701K |
|
|
PGNX
904
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $113K | ﹤0.01% |
21,500
-21,500
| -50% | -$107K |
|
905
Elbit Systems
ESLT
$40.3B
| $108K | ﹤0.01% |
654
-493
| -43% | -$77.7K |
|
|
CLVS
906
DELISTED
Clovis Oncology, Inc.
CLVS
| $108K | ﹤0.01% |
26,989
-18,600
| -41% | -$150K |
|
|
CCXI
907
DELISTED
ChemoCentryx, Inc.
CCXI
| $108K | ﹤0.01% |
16,500
-16,500
| -50% | -$124K |
|
908
MKS Inc
MKSI
$20.6B
| $105K | ﹤0.01% |
1,156
-1,193
| -51% | -$98.5K |
|
|
WPX
909
DELISTED
WPX Energy, Inc.
WPX
| $104K | ﹤0.01% |
10,000
-10,000
| -50% | -$106K |
|
910
BioCryst Pharmaceuticals
BCRX
$2.4B
| $100K | ﹤0.01% |
31,500
-31,500
| -50% | -$98K |
|
911
Gaming and Leisure Properties
GLPI
$12.8B
| $100K | ﹤0.01% |
2,616
| – | – |
|
|
PTR
912
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $100K | ﹤0.01% |
2,000
| – | – |
|
913
Prothena Corp
PRTA
$450M
| $99K | ﹤0.01% |
12,650
-12,650
| -50% | -$112K |
|
914
Rithm Capital
RITM
$5.69B
| $99K | ﹤0.01% |
6,364
| – | – |
|
915
Fabrinet
FN
$20.1B
| $98K | ﹤0.01% |
1,901
-1,734
| -48% | -$90.8K |
|
916
Atara Biotherapeutics
ATRA
$76.1M
| $97K | ﹤0.01% |
288
-288
| -50% | -$107K |
|
917
EQT Corp
EQT
$32.3B
| $93K | ﹤0.01% |
8,247
| – | – |
|
918
Rigel Pharmaceuticals
RIGL
$750M
| $93K | ﹤0.01% |
5,100
-5,100
| -50% | -$105K |
|
|
TXNM
919
TXNM Energy Inc
TXNM
$5.94B
| $92K | ﹤0.01% |
1,781
-1,837
| -51% | -$92.7K |
|
920
Medifast
MED
$141M
| $91K | ﹤0.01% |
900
| – | – |
|
921
Charles River Laboratories
CRL
$12.8B
| $89K | ﹤0.01% |
668
-649
| -49% | -$87K |
|
922
Nexstar Media Group
NXST
$5.97B
| $89K | ﹤0.01% |
890
-271
| -23% | -$27.4K |
|
|
MLNX
923
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $87K | ﹤0.01% |
787
-10,166
| -93% | -$1.12M |
|
|
SWN
924
DELISTED
Southwestern Energy Company
SWN
| $82K | ﹤0.01% |
40,191
-59,115
| -60% | -$127K |
|
925
Louisiana-Pacific
LPX
$5.49B
| $80K | ﹤0.01% |
3,200
-74,500
| -96% | -$1.84M |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2019 Portfolio in Review
As of Q3 2019, DekaBank Deutsche Girozentrale held 1,193 positions worth $16.1B, down 19% from $19.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.99B in Q3 2019, closing 205 positions and reducing 579 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in Ambarella worth $4.97M.
- DekaBank Deutsche Girozentrale's largest Q3 2019 buy was Ambarella: 80,000 shares worth $4.97M.
- DekaBank Deutsche Girozentrale added most to Philip Morris in Q3 2019, an estimated $107M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2019 reduction was Microsoft, cutting an estimated $112M.
- DekaBank Deutsche Girozentrale fully exited Alphabet (Google) Class A in Q3 2019, selling an estimated $383M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $16.1B portfolio in Q3 2019.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 205 in Q3 2019.
- DekaBank Deutsche Girozentrale's portfolio value fell 19% quarter-over-quarter to $16.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.